Transplantation, Homologous
"Transplantation, Homologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.
| Descriptor ID |
D014184
|
| MeSH Number(s) |
E04.936.864
|
| Concept/Terms |
Transplantation, Homologous- Transplantation, Homologous
- Transplantation, Allogeneic
- Homografting
- Homologous Transplantation
- Allogeneic Transplantation
- Allografting
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Homologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Homologous".
This graph shows the total number of publications written about "Transplantation, Homologous" by people in this website by year, and whether "Transplantation, Homologous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation, Homologous" by people in Profiles.
-
Bone Marrow Aspirate Concentrate Augmentation May Accelerate Allograft Ligamentization in Anterior Cruciate Ligament Reconstruction: A Double-Blinded Randomized Controlled Trial. Arthroscopy. 2022 07; 38(7):2255-2264.
-
Type 1 interferon to prevent leukemia relapse after allogeneic transplantation. Blood Adv. 2021 12 14; 5(23):5047-5056.
-
Viral kinetics and outcomes of adenovirus viremia following allogeneic hematopoietic cell transplantation. Clin Transplant. 2021 12; 35(12):e14481.
-
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients. Leuk Lymphoma. 2020 12; 61(12):2811-2820.
-
Significance of isolated deletion (20q) in donor cells after allogeneic hematopoietic cell transplantation. Leuk Lymphoma. 2020 08; 61(8):2008-2011.
-
Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation. Biol Blood Marrow Transplant. 2020 06; 26(6):1099-1105.
-
Long-Term Comparison Between Pulmonary Homograft Versus Bioprosthesis for Pulmonary Valve Replacement in Tetralogy of Fallot. J Am Heart Assoc. 2019 12 17; 8(24):e013654.
-
Allogeneic transplantation in elderly patients =65 years with non-Hodgkin lymphoma: a time-trend analysis. Blood Cancer J. 2019 12 03; 9(12):97.
-
Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis. Biol Blood Marrow Transplant. 2019 10; 25(10):2086-2090.
-
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure. Cancer. 2018 06 15; 124(12):2541-2551.